Endpoints News 2026年3月25日 Maze meets own expectations in Phase 2 kidney disease trial in the same arena as Vertex
Endpoints News 2026年3月25日 Merck to buy Terns for $6.7B, taking a leukemia drug that could challenge Novartis' Scemblix
Endpoints News 2026年3月24日 Karyopharm’s mixed myelofibrosis data; Rezolute to seek FDA approval despite trial failure
Endpoints News 2026年3月24日 Q&A: Controversial embryo editing entrepreneur Cathy Tie on her new startup
Endpoints News 2026年3月24日 Apnimed set to exit sleep disorder joint venture with Shionogi for $100M upfront
Endpoints News 2026年3月24日 Gilead bets $1.68B upfront on Ouro Medicines’ autoimmune program, with Galapagos expected to pitch in
Endpoints News 2026年3月24日 Merck partners with Flagship startup Quotient to search for genetic clues to IBD
Endpoints News 2026年3月23日 Former Acorda CEO Ron Cohen emerges at Parkinson’s cell therapy biotech Oryon